So, AI-predicted labels are consistent with the clinical algorithm that expects NV AMD patients to be positive for CNV or IRF/SRF, and NNV AMD patients to be negative for CNV and IRF/SRF, but not to as high of an extent as the expert labels. This evidence concerns the gene SRF and age-related macular degeneration.